摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-Methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine

中文名称
——
中文别名
——
英文名称
7-Methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine
英文别名
11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3,5,7,14,16-hexaene
7-Methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine化学式
CAS
——
化学式
C18H21N
mdl
——
分子量
251.371
InChiKey
BXOLXXSMCLYDNG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-(1-苯基-3,4-二氢-1H-异喹啉-2-基)-乙醇 在 PPA 、 sodium 作用下, 以 乙醇丙酮 为溶剂, 反应 26.0h, 生成 7-Methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine
    参考文献:
    名称:
    Dopamine/Serotonin Receptor Ligands. 10: SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D1, D2L, and D5 Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D1/D5 Selective Antagonist
    摘要:
    On the basis of the benz[d]indolo[2,3-g]azecine derivative I (LE300), structure-activity relations were investigated in order to identify the pharmacophore in this new class of ligands. Various structural modifications were performed and the inhibitory activities at human cloned D-1, D-2L, and D-5 receptors were measured by using a simple fluorescence microplate reader based calcium assay. Subsequently, the affinities of active compounds were estimated by radioligand binding experiments. Deleting one of the aromatic rings as well as replacing it by a phenyl moiety abolishes the inhibitory activities almost completely. Contraction of the 10-membered central ring decreases them significantly. The replacement of indole by thiophene or N-methylpyrrole reduces the inhibitory activity, whereas replacing the indole by benzene increases it. Finally, the hydroxylated dibenz[d,g]azecine derivative 11d (LE404) was found to be more active than the lead I in the functional calcium assay as well as in radioligand displacement experiments.
    DOI:
    10.1021/jm050846j
点击查看最新优质反应信息

文献信息

  • Dopamine/Serotonin Receptor Ligands. 10: SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D<sub>1</sub>, D<sub>2L</sub>, and D<sub>5</sub> Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D<sub>1</sub>/D<sub>5</sub> Selective Antagonist
    作者:Barbara Hoefgen、Michael Decker、Patrick Mohr、Astrid M. Schramm、Sherif A. F. Rostom、Hussein El-Subbagh、Peter M. Schweikert、Dirk R. Rudolf、Matthias U. Kassack、Jochen Lehmann
    DOI:10.1021/jm050846j
    日期:2006.1.1
    On the basis of the benz[d]indolo[2,3-g]azecine derivative I (LE300), structure-activity relations were investigated in order to identify the pharmacophore in this new class of ligands. Various structural modifications were performed and the inhibitory activities at human cloned D-1, D-2L, and D-5 receptors were measured by using a simple fluorescence microplate reader based calcium assay. Subsequently, the affinities of active compounds were estimated by radioligand binding experiments. Deleting one of the aromatic rings as well as replacing it by a phenyl moiety abolishes the inhibitory activities almost completely. Contraction of the 10-membered central ring decreases them significantly. The replacement of indole by thiophene or N-methylpyrrole reduces the inhibitory activity, whereas replacing the indole by benzene increases it. Finally, the hydroxylated dibenz[d,g]azecine derivative 11d (LE404) was found to be more active than the lead I in the functional calcium assay as well as in radioligand displacement experiments.
查看更多

同类化合物

5-formyl-2-cyclopentylmethyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo[3,4:6,7]cyclohepta[1,2-c]pyrrole hydrochloride dibenzo[i,k]-benzo[4,5]imidazo[1,2-f]phenanthridine 2-{4-[9-(5,8,9,14-tetrahydrodibenzo[d,g]azecin-7(6H)-yl)nonyl]piperazin-1-yl}ethanol (2R,3aR,12bS)-11-fluoro-2-[(methylamino)methyl]-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrole-1(2H)-carbaldehyde [(2R,3aR,12bS)-11-fluoro-1-(methoxyacetyl)-1,2,3,3a,8,12b-hexahydrodibenzo-[3,4:6,7]cyclohepta[1,2-b]pyrrol-2-yl]-N,N-dimethylmethanamine 2-[(2R,3aR,12bS)-2-[(dimethylamino)methyl]-11-fluoro-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrol-1(2H)-1-yl]ethanol [(2R,3aR,12bS)-11-fluoro-1-(2-methoxyethyl)-1,2,3,3a,8,12b-hexahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrol-2-yl]-N,N-dimethylmethanamine [(2R,3aR,12bS)-11-fluoro-1-methyl-1,2,3,3a,8,12b-hexahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrol-2-yl]-N,N-dimethylmethanamine methyl (2R,3aR,12bS)-2-(aminomethyl)-11-fluoro-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrole-1(2H)-carboxylate 6-allyl-3,4-dimethoxy-10-hydroxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 6,7,15-trimethyl-7-nitro-5,6,6a,7,8,13,14,14a-octahydro-5,13-cyclo-8,14-epiazano-benzo[5,6]cycloocta[1,2-c]isoquinoline 6-Benzyl-3,4-dimethoxy-10-hydroxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 3,4-Dimethoxy-11-hydroxy-6-methyl-5,6,7,8.13,14-hexahydrodibenz[c,g]azecine 6-benzyl-3,4-dimethoxy-11-hydroxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 2,3-dimethoxy-7-methyl-5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizinium iodide 5,6-Dimethoxy-11-methyl-11-aza-tricyclo[12.4.0.03,8]octadeca-1(14),3(8),4,6,15,17-hexaene (3S,3aR,12bS)-8-Dicyanomethylene-2,3-diphenyl-3,3a,8,12b-tetrahydro-2H-dibenzo[3,4;6,7]cyclohepta[1,2-c]pyrrole-1,1-dicarboxylic acid dimethyl ester (3S,3aR,12bS)-8-Dicyanomethylene-2-phenyl-3,3a,8,12b-tetrahydro-2H-dibenzo[3,4;6,7]cyclohepta[1,2-c]pyrrole-1,1,3-tricarboxylic acid trimethyl ester markiertes 2-Nitro-4,13-dimethyl-4,13-diazadibenzo<6.7,11,12>tetracyclo<7.3.1.03,8.05,10>tridecadien-(6,11) 3,4-dimethoxy-6-methyl-5,6,7,8,13,14-hexahydro-dibenzo[c,g]azecin-10-ol (2R,3aR,12bS)-11-fluoro-2-(hydroxymethyl)-3,3a,8,12b-tetrahydrodibenzo[3,4:6,7]cyclohepta[1,2-b]pyrrole-1(2H)-carbaldehyde 1H-3a,8-Methanodibenzo(3,4:6,7)cyclohepta(1,2-c)pyrrole, 2,3,8,12b-tetrahydro-2-(cyclohexylmethyl)-8-methyl-, hydrochloride, (3a-alpha,8-alpha,12b-beta)- 1H-3a,8-Methanodibenzo(3,4:6,7)cyclohepta(1,2-c)pyrrole, 2,3,8,12b-tetrahydro-2-(cyclopentylmethyl)-1-methyl-, hydrochloride, (1-alpha,3a-alpha,8-alpha,12b-beta)- 3,12-dimethyl-3-azapentacyclo[10.6.1.01,5.06,11.013,18]nonadeca-6,8,10,13,15,17-hexaene;hydron;chloride 14-hydroxy-3,4-dimethoxy-5,6,7,8,14,15-hexahydrobenzo<1,3>dioxolo<4,5-k><3>benzazecine-6-carbonitrile 7-methyl-5,6,7,8,9,15-hexahydrobenzo[d][1,3]benzodioxolo[5,6-g]azecine 6-Acetyl-3,4-dimethoxy-5,8,14,15-tetrahydro-6H-benzo[c][1,3]dioxolo[4',5':4,5]benzo[1,2-g]azecin-7-one 6-benzyl-3,4-dimethoxy-10,11-methylenedioxy-5,6,7,8,13,14-hexahydrodibenz[c,g]azecine 4MP-Dhx 6-methyl-5,6,7,8,9,14-hexahydrodibenzo[c,f]azecin-11-ol 10-methoxy-6-methyl-5,6,7,8,13,14-hexahydrodibenzo[c,g]azecine 3,3a(2)-[1,3-Propanediylbis(oxy)]bis[5,8,9,13b-tetrahydro-7-methyl-6H-dibenzo[a,h]quinolizinium] 7-methyl-6,7,8,9-tetrahydrodibenz[d,g]azecin-14(5H)-one N-benzyl-N-nordihydroallocryptopine 2-Methyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo<3,4;6,7>cyclohepta<1,2-c>pyrrol-1-on dihydroallocryptopine 3-methoxy-7-methyl-6,7,8,9-tetrahydrodibenz[d,g]azecin-14(5H)-one (6aR,12bS)-(+)-6-((R)-α-methoxyphenylacetyl)-10,11-dimethoxy-5,6,6a,7,8,12b-hexahydrobenzophenanthridine (6aS,12bR)-(-)-6-((R)-α-methoxyphenylacetyl)-10,11-dimethoxy-5,6,6a,7,8,12b-hexahydrobenzophenanthridine 2-cyclopentylmethyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo[3,4:6,7]cyclohepta[1,2-c]pyrrole 5-formyl-2-cyclopentylmethyl-2,3,8,12b-tetrahydro-1H-3a,8-methanodibenzo[3,4:6,7]cyclohepta[1,2-c]pyrrole (1S,2S,9R,11R,12S,13S,20R)-10,21-dimethyl-12-nitro-10,21-diazahexacyclo[11.7.1.02,11.03,8.09,20.014,19]henicosa-3,5,7,14,16,18-hexaene (1S,2S,9S,11R,12S,13S,20R)-10,21-dimethyl-12-nitro-10,21-diazahexacyclo[11.7.1.02,11.03,8.09,20.014,19]henicosa-3,5,7,14,16,18-hexaene 6-benzyl-10,11-dimethoxy-2-phenyl-6a,7,8,12b-tetrahydro-5H-benzo[a]phenanthridine 6-Propyl-5,6,6a,7,8,12b-hexahydro-benzo[a]phenanthridine-10,11-diol (2S)-7,8-dimethoxy-11-methyl-17,19-dioxa-11-azoniatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-ol (2R)-7,8-dimethoxy-11-methyl-17,19-dioxa-11-azoniatetracyclo[12.7.0.04,9.016,20]henicosa-1(21),4(9),5,7,14,16(20)-hexaen-2-ol 7-Methyl-5,6,7,8,9,14-hexahydrodibenzo[d,g]azecine (3R)-15-methyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-ol (3S)-15-methyl-7,9,19,21-tetraoxa-15-azapentacyclo[15.7.0.04,12.06,10.018,22]tetracosa-1(17),4,6(10),11,18(22),23-hexaen-3-ol